These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16092094)

  • 1. Therapeutic strategies in multiple system atrophy.
    Wenning GK; Geser F; Poewe W
    Mov Disord; 2005 Aug; 20 Suppl 12():S67-76. PubMed ID: 16092094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple system atrophy.
    Wenning GK; Geser F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S31-8. PubMed ID: 12773886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple system atrophy: an update.
    Wenning GK; Geser F; Stampfer-Kountchev M; Tison F
    Mov Disord; 2003 Sep; 18 Suppl 6():S34-42. PubMed ID: 14502654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonism. Multiple system atrophy.
    Wenning GK; Quinn NP
    Baillieres Clin Neurol; 1997 Apr; 6(1):187-204. PubMed ID: 9426875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
    Köllensperger M; Geser F; Ndayisaba JP; Boesch S; Seppi K; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Klockgether T; Yekhlef F; Tison F; Daniels C; Deuschl G; Coelho M; Sampaio C; Bozi M; Quinn N; Schrag A; Mathias CJ; Fowler C; Nilsson CF; Widner H; Schimke N; Oertel W; Del Sorbo F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Colosimo C; Meco G; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Rascol O; Kamm C; Gasser T; Siebert U; Poewe W; Wenning GK;
    Mov Disord; 2010 Nov; 25(15):2604-12. PubMed ID: 20922810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple system atrophy].
    Damon-Perrière N; Tison F; Meissner WG
    Psychol Neuropsychiatr Vieil; 2010 Sep; 8(3):179-91. PubMed ID: 20739256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and therapy of multiple system atrophy].
    Wenning GK; Seppi K
    Praxis (Bern 1994); 2001 Jun; 90(23):1035-40. PubMed ID: 11447723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
    Jellinger KA; Seppi K; Wenning GK
    Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic failure in neurodegenerative disorders.
    Kaufmann H; Biaggioni I
    Semin Neurol; 2003 Dec; 23(4):351-63. PubMed ID: 15088256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red flags for multiple system atrophy.
    Köllensperger M; Geser F; Seppi K; Stampfer-Kountchev M; Sawires M; Scherfler C; Boesch S; Mueller J; Koukouni V; Quinn N; Pellecchia MT; Barone P; Schimke N; Dodel R; Oertel W; Dupont E; Østergaard K; Daniels C; Deuschl G; Gurevich T; Giladi N; Coelho M; Sampaio C; Nilsson C; Widner H; Sorbo FD; Albanese A; Cardozo A; Tolosa E; Abele M; Klockgether T; Kamm C; Gasser T; Djaldetti R; Colosimo C; Meco G; Schrag A; Poewe W; Wenning GK;
    Mov Disord; 2008 Jun; 23(8):1093-9. PubMed ID: 18442131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple system atrophy of the cerebellar type: clinical state of the art.
    Lin DJ; Hermann KL; Schmahmann JD
    Mov Disord; 2014 Mar; 29(3):294-304. PubMed ID: 24615754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of multiple system atrophy: state of the art.
    Colosimo C; Tiple D; Wenning GK
    J Neural Transm (Vienna); 2005 Dec; 112(12):1695-704. PubMed ID: 16284911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in clinical diagnostic criteria for multiple system atrophy].
    Tison F
    Rev Neurol (Paris); 2000 Sep; 156(8-9):711-7. PubMed ID: 10992115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple system atrophy--update].
    Sasaki H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):979-81. PubMed ID: 15651348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of multiple system atrophy in Moroccan patients attending a movement disorders outpatient clinic in Rabat university hospital.
    Regragui W; Lachhab L; Razine R; Benjelloun H; Ait Benhaddou EH; Benomar A; Yahyaoui M
    Rev Neurol (Paris); 2013 Feb; 169(2):121-5. PubMed ID: 22763206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus statement on the diagnosis of multiple system atrophy.
    Gilman S; Low PA; Quinn N; Albanese A; Ben-Shlomo Y; Fowler CJ; Kaufmann H; Klockgether T; Lang AE; Lantos PL; Litvan I; Mathias CJ; Oliver E; Robertson D; Schatz I; Wenning GK
    J Auton Nerv Syst; 1998 Dec; 74(2-3):189-92. PubMed ID: 9915636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopaminergic treatment and parkinsonian syndromes].
    Ghawche F; Durif F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S83-6. PubMed ID: 12773892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MSA update].
    Tsuji S
    Rinsho Shinkeigaku; 2005 Nov; 45(11):821-3. PubMed ID: 16447735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.
    Yabe I; Soma H; Takei A; Fujiki N; Yanagihara T; Sasaki H
    J Neurol Sci; 2006 Nov; 249(2):115-21. PubMed ID: 16828805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential outcome measures and trial design issues for multiple system atrophy.
    May S; Gilman S; Sowell BB; Thomas RG; Stern MB; Colcher A; Tanner CM; Huang N; Novak P; Reich SG; Jankovic J; Ondo WG; Low PA; Sandroni P; Lipp A; Marshall FJ; Wooten F; Shults CW;
    Mov Disord; 2007 Dec; 22(16):2371-7. PubMed ID: 17914727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.